Screening of specific antigens for SARS clinical diagnosis using a protein microarray

Analyst

Volumn 130, Issue 4, 2005, Pages 474-482

  Lu, Dan Dan ^a   Chen, Su Hong ^a   Zhang, Shi Meng ^a   Zhang, Min Li ^a   Zhang, Wei ^a   Bo, Xiao Chen ^a   Wang, Sheng Qi ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE N2 FUSION PROTEIN; HYBRID PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PROTEIN MICROARRAY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 17144428961     PISSN: 00032654     EISSN: None     Source Type: Journal    
DOI: 10.1039/b415888a     Document Type: Article

References (26)

1. S. M. Poutanen, D. E. Low, B. Henry, S. Finkelstein, D. Rose and K. Green, et al., Identification of severe acute respiratory syndrome in Canada, N. Engl. J. Med., 2003, 348, 1995-2005.
2. N. Lee, D. Hui, A. Wu, P. Chan, P. Cameron and G. M. Joynt, et al., A major outbreak of severe acute respiratory syndrome in Hong Kong, N. Engl. J. Med., 2003, 348, 1986-1994.
3. J. S. M. Peiris, S. T. Lai, L. L. M. Poon, Y. Guan, L. Y. C. Yam and W. Lim, et al., Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 2003, 361, 1319-1325.
4. T. G. Ksiazek, D. Erdman, C. Goldsmith, S. R. Zaki, T. Peret and S. Emery, et al., A novel coronavirus associated with severe acute respiratory syndrome, N. Engl. J. Med., 2003, 348, 1953-1966.
5. P. A. Rota, M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli and J. P. Icenogle, et al., Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science, 2003, 300, 1394-1399.
6. M. A. Marra, S. J. M. Jones, C. R. Astell, R. A. Holt, A. Brooke-Wilson and Y. S. N. Butterfield, et al., The genome sequence of the SARS-associated coronavirus, Science, 2003, 300, 1399-1404.
7. E. D. Qin, Q. Y. Zhu, M. Yu, B. C. Fan, G. H. Chang and B. Y. Si, et al., A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01), Chin. Sci. Bull., 2003, 48, 941-948.
8. L. Enjuanes, C. Smerdou, J. Castilla, I. M. Anton, J. M. Torres and I. Sola, et al., Development of protection against coronavirus induced disease, Adv. Exp. Med. Biol., 1995, 380, 197-211.
9. C. L. Yeager, R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro and A. T. Look, et al., Human aminopeptidase N is a receptor for human coronavirus 229E, Nature, 1992, 357, 420-422.
10. C. A. M. de Haan, M. Smeets, F. Vernooij, H. Vennema and P. J. M. Rottier, Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein, J. Virol., 1999, 73, 7441-7452.
11. A. Lueking, M. Horn, H. Eickhoff, K. Bussow, H. Lehrach and G. Walter, Protein microarrays for gene expression and antibody screening. Anal. Biochem., 1999, 270, 103-111.
12. G. MacBeath and S. L. Schreiber, Printing proteins as microarrays for high-throughput function determination, Science, 2000, 289, 1760-1763.
13. L. Mezzasoma, T. Bacarese-Hamilton, M. Di Cristina, R. Rossi, F. Bistoni and A. Crisanti, Antigen microarrays for serodiagnosis of infectious diseases, Clin. Chem., 2002, 48, 121-130.
14. J. Sambrook and D. W. Russell, Molecular Cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New York, 3rd edn., 2001.
15. M. Schena, D. Shalon, R. W. David and P. O. Brown, Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science, 1995, 270, 467-470.
16. D. Shalon, S. J. Smith and P. O. Brown, A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization, Genome Res., 1996, 6, 639-645.
17. M. C. Mechin, M. Der Vartanian and C. Martin, The major subunit ClpG of Escherichia coli CS31A fibrillae as an expression vector for different combinations of two TGEV coronavirus epitopes, Gene, 1996, 179, 211-218.
18. Y. L. Shi, Y. P. Yi, P. Li, T. J. Kuang, L. H. Li and M. Dong, et al., Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay, J. Clin. Microbiol., 2003, 41, 5781-2.
19. K. L. Hon, A. M. Li, F. W. Cheng, T. F. Leung and P. C. Ng, Personal view of SARS: confusing definition, confusing diagnosis, Lancet, 2003, 361, 1984-1985.
20. L. Kuo and P. S. Masters, Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J. Virol., 2002, 76, 4987-4999.
21. K. Narayanan, C. J. Chen, J. Maeda and S. Makino, Nucleocapsid- independent specific viral RNA packaging via viral envelope protein and viral RNA signal, J. Virol. 2003, 77, 2922-2927.
22. L. Yu, W. Liu, W. M. Schnitzlein, D. N. Tripathy and J. Kwang, Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid proteins of infectious bronchitis virus against challenge, Avion Dis., 2001, 45, 340-348.
23. J. A. Hiscox, T. Wurm, L. Wilson, P. Britton, D. Cavanagh and G. Brooks, The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus, J. Virol., 2001, 75, 506-512.
24. C. Liu, T. Kokuho, T. Kubota, S. Watanabe, S. Inumaru and Y. Yokomizo, et al., DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus, Virus Res., 2001, 80, 75-82.
25. M. M. Lai and D. Cavanagh, The molecular biology of coronaviruses, Adv. Virus Res., 1997, 48, 1-100.
26. S. K. Wootton, E. A. Nelson and D. Yoo, Antigenic structure of the nucleocapsid protein of porcine reproductive and respiratory syndrome virus, Clin. Diagn Lab. Immunol., 1998, 5, 773-779.